Searched for
AARTI DRUGS SHARES
Earnings season is strong, but Q1 pain is coming: Dipan MehtaMarket expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...- Aarti Drugs share buyback: Last day to buy for eligibilityAarti Drugs has set September 5 as the record date for its Rs 60 crore share buyback, making today the last day to buy shares to be eligibl...
- Aarti Drugs shares zoom 5% on Rs 60 crore buyback announcementAarti Drugs Share Price: Aarti Drugs shares surged 5% to Rs 634.90 on BSE after announcing a Rs 60 crore buyback of 6.65 lakh shares at Rs ...
- Share buyback fuels Aarti Drugs rally, stock jumps 13%Aarti Drugs Share Price: Aarti Drugs' shares saw a 13% rise on the BSE following the company’s announcement of a potential share buyback, t...
- Aarti Drugs shares skyrocket over 19% on Q1 results and buyback announcementFurther, the board has approved a buyback not exceeding 6,65,000 lakh equity shares for an amount not exceeding Rs 59.85 crore. The buyback...
- Hold Aarti Drugs, target price Rs 435: Axis SecuritiesAarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 3757.71 Crore) operating in Pharmaceutic...
- Buy Aarti Drugs, target price Rs 552: HDFC SecuritiesAarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 4405.91 Crore) operating in Pharmaceutic...
- Buy Aarti Drugs, target price Rs 836: Anand RathiAarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 5781.02 Crore) operating in Pharmaceutic...
- Aarti Drugs' board to consider shares buyback later this weekThe company, which manufactures bulk drugs and chemicals, did not elaborate on the size of the shares buyback.
- Can this Mumbai wealth creator give D-Street a third multi-bagger?While two of its stocks have delivered more than 4,000 per cent returns over the past decade and continue the stellar run, all eyes are now...
- Aarti Drugs approves 3:1 bonus issue, shares jump 16% to record highThe company, which manufactures bulk drugs and chemicals, said on Monday its board will meet later this week to consider a proposal for iss...
- Aarti Drugs board to consider issue of bonus sharesThe next meeting of "the board of directors of the company is scheduled to be held on Thursday, August 20, 2020 to consider a proposal for ...
- Buy Aarti Drugs, target price Rs 1,028: Anand RathiThe brokerage expects revenue and PAT CAGRs over FY20-22 of respectively 14.4 per cent and 31.8 per cent.
- Buy Aarti Drugs, target Rs 796: Anand RathiAarti Drugs is a smallcap company, operating in pharmaceuticals and health care sector.
- Buy Aarti Drugs, target Rs 720: Anand RathiBuy Aarti Drugs Ltd. at a price target of Rs 720.0 .
- Aarti Drugs scales fresh 52-week high on fixing record date for buybackInga Capital has been appointed as the manger to the proposed buyback.
- Aarti Drugs' board to consider shares buyback next weekShares of Aarti Drugs were trading 3.45 per cent higher at Rs 730.20 on BSE.
- Aarti Drugs Q4 net profit up 11.51% at Rs 21 croreThe company had posted a net profit of Rs 18.59 crore for the corresponding period of previous fiscal.
- Aarti Drugs climbs 3% as board announces buyback planThe company said it would buy shares at a price not more than Rs 750 apiece. Following the announcement, the stock rose 4.25 per cent to hi...
- Aarti Drugs Q1 net up 92 per cent at Rs 8.88 croreAarti Drugs today posted 92.21 per cent rise in net profit at Rs 8.88 crore for the first quarter ended June 30.
Load More
